APA (7th ed.) Citation

Nonomura, N., Ito, T., Sato, M., Morita, M., Ogi, M., Kajita, M., & Oya, M. Final Analysis of Post‐Marketing Surveillance for Avelumab + Axitinib in Patients With Renal Cell Carcinoma in Japan. Wiley.

Chicago Style (17th ed.) Citation

Nonomura, Norio, Taito Ito, Masashi Sato, Makiko Morita, Mie Ogi, Masahiro Kajita, and Mototsugu Oya. Final Analysis of Post‐Marketing Surveillance for Avelumab + Axitinib in Patients With Renal Cell Carcinoma in Japan. Wiley.

MLA (9th ed.) Citation

Nonomura, Norio, et al. Final Analysis of Post‐Marketing Surveillance for Avelumab + Axitinib in Patients With Renal Cell Carcinoma in Japan. Wiley.